Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe

Evan P Lebois1, Gregory J Digby, Douglas J Sheffler

  • 1Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.